Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC10225 Lidocaine hydrochloride Lidocaine hydrochloride is a local anesthetic and cardiac depressant used as an antiarrhythmia agent.
DC8986 Lidocaine Lidocaine, an amide local anesthetic, has anti-inflammatory properties in vitro and in vivo, possibly due to an attenuation of pro-inflammatory cytokines, intracellular adhesion molecule-1 (ICAM-1), and reduction of neutrophils influx.
DC20198 Lifirafenib;BGB-283;Beigene-283 Lifirafenib (BGB-283) potently inhibits RAF family kinases and EGFR activities in biochemical assays with IC50 values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.
DC10099 BGB283 Lifirafenib(BGB-283) is a Novel potent and selective RAF Kinase and EGFR inhibitor.
DC26014 Lifitegrast sodium Featured Lifitegrast sodium, also known as SAR-1118, is an LFA-1 antagonist intended for the treatment of vascular complications of the eye.
DC23065 Ligustilide Featured Ligustilide possesses neuroprotective, vasorelaxation, antinociceptive and anti-inflammatory activities, it blocked the activation of MAPKs/IKK and the downstream transcription factors AP-1 and NF-κB.
DC21914 LIMK1 and 2 dual inhibitor LIMK1 and 2 dual inhibitor is a potent, selective LIMK1/2 inhibitor with IC50 of <10 nM for both, 15-fold selectivity over B-Raf (IC50=10-100 nM).
DC21915 LIN28 inhibitor LI71 Featured LIN28 inhibitor LI71 is a potent, cell-permeable inhibitor of LIN28 that abolishes LIN28-mediated oligouridylation with IC50 of 7 uM, binds the cold shock domain to suppress LIN28's activity against let-7 in leukemia cells and embryonic stem cells. .
DC20436 Lin28-IN-1 Lin28-IN-1 is a small-molecule inhibitor of the Lin28/let-7 interaction with IC50 of 4.03 uM.
DC1105 Linagliptin (BI-1356) Featured Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM.
DCAPI1373 Lincomycin HCl (Lincocin) Lincomycin HCl (Lincocin)
DC23026 Linderane Featured Linderane is a mechanism-based inactivator of CYP2C9.
DC6905 Linezolid (PNU-100766) Featured Linezolid (Zyvox) is a synthetic antibiotic used for the treatment of serious infections.
DC10820 Roquinimex(Linomide) Featured Linomide is an Immunomodulator; anti-angiogenic.
DC20982 Linopirdine dihydrochloride Linopirdine (DUP-996) is a potent Kv7 (KCNQ) voltage-gated potassium channels blcoker.
DC20983 Linopirdine Linopirdine (DUP-996.
DC9188 Liothyronine sodium Featured Liothyronine sodium (T3 Sodium sal) is the most potent form of thyroid hormone used to treat hypothyroidism and myxedema coma.
DC11011 Lipofermata Featured Lipofermata (CB16.2 aka) is a specific fatty acid transport (FATP) inhibitor, blocks human FATP2-mediated fatty acid uptake (IC50=4.84 uM in Caco-2 cells) without impacting other cellular functions.
DC26056 Liproxstatin-1 analog Liproxstatin-1 analog is an analog of the ferroptosis inhibitor liproxstatin-1
DC7920 Liproxstatin-1 Featured Liproxstatin-1 is able to suppress ferroptosis in cells, in Gpx4(-/-) mice, and in a pre-clinical model of ischaemia/reperfusion-induced hepatic damage.
DC8927 Liraglutide Featured Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus.
DC23664 Lirimilast Lirimilast (BAY 19-8004.
DC9123 Lisinopril Dihydrate Lisinopril Dihydrate is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.
DC12433 LIT-001 Featured LIT-001 (LIT001) is the first nonpeptide Oxytocin receptor (OT-R) agonist with EC50 of 55 nM, Emax=96%.
DC12434 LIT-001 trifluoroacetate Featured LIT-001 trifluoroacetate (LIT001) is the first nonpeptide Oxytocin receptor (OT-R) agonist with EC50 of 55 nM, Emax=96%.
DC8689 Litronesib Litronesib is a selective, allosteric inhibitor of Eg5, which may result in mitotic disruption, apoptosis and consequently cell death in tumor cells that are actively dividing.
DC4138 Lixivaptan (VPA-985) Featured Lixivaptan is a highly potent, non-peptide, oral capsule that works by reducing the action of a hormone (vasopressin) that blocks fluid excretion.
DC21233 LJ 001 Featured LJ 001 ((LJ-001, LJ001) is a broad-spectrum antiviral agent targeting entry of enveloped viruses, including influenza A, filoviruses, poxviruses, arenaviruses, bunyaviruses, paramyxoviruses, flaviviruses, and HIV-1; specifically intercalates into viral membranes, irreversibly inactivates virions while leaving functionally intact envelope proteins, and inhibits viral entry at a step after virus binding but before virus-cell fusion; specifically inhibits virus-cell but not cell-cell fusion
DC8811 LJH-685 Featured LJH685 is a selective and potent RSK inhibitor.
DC8812 LJI-308 Featured LJI308 is a selective and potent RSK inhibitor.

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X